| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,379 | 17,098 | 16,992 | 17,821 | | Cost of Revenue | 4,172 | 4,729 | 4,975 | 6,213 | | | Gross Profit |
-
| 12,369 | 12,017 | 11,608 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,091 | 11,461 | 7,084 | 6,357 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,497 | 12,469 | 7,719 | 8,330 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (11,561) | (2,786) | (3,079) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,619 | (11,561) | (2,786) | (3,079) | | Interest Expense | 1,563 | 1,573 | 1,596 | 1,592 | | Income Before Tax | 1,056 | (13,134) | (4,382) | (4,671) | | Income Tax Expense | 175 | (3,930) | (1,760) | (2,133) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 881 | (9,204) | (2,622) | (2,538) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 881 | (9,204) | (2,622) | (2,538) | | Preferred Stock And Other Adjustments | (438) | (439) | (429) | (37) | | | Net Income Applicable To Common Shares | $443 | ($9,643) | ($3,051) | ($2,575) |
|
0.02% Nasdaq 0.00%
Income Statement
